SCHEMBL7182884

SCHEMBL7182884

CC(CNC(=O)c1c[c]cc(Nc2ccccc2)c1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 4/20 0.45
TP53 P04637 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ROCK2 O75116 2/20 0.42
ROCK1 Q13464 2/20 0.42
BCL2 P10415 4/20 0.42
BCL2L1 Q07817 4/20 0.42
MCL1 Q07820 4/20 0.42
BCL2A1 Q16548 4/20 0.42
BAK1 Q16611 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195286 0.89 KMT2A (0.52) MAPTSMN1; SMN2LMNA
SCHEMBL7561990 0.82 NPC1 (0.50) NPC1RAB9AMAPTTP53SMN1; SMN2
SCHEMBL7592814 0.82 HDAC6 (0.43) MAPTLMNA
SCHEMBL7674538 0.78 SIRT2 (0.51) NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL2481230 0.77 NPC1 (0.67) NPC1RAB9AMAPTTP53SMN1; SMN2
SCHEMBL5709362 0.77 NPC1 (0.67) NPC1RAB9AMAPTTP53SMN1; SMN2
SCHEMBL8162012 0.72 NPC1 (0.61) NPC1RAB9AMAPTTP53SMN1; SMN2
SCHEMBL7597518 0.71 TP53 (0.50) NPC1RAB9AMAPTTP53LMNA
SCHEMBL7182870 0.71 IMPDH2 (0.44) RAB9AMAPTROCK2ROCK1
SCHEMBL6196126 0.71 NPC1 (0.57) NPC1RAB9AMAPTTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274676-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 1,4-QUINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE Pharmacia Corporation (US) 2003-01-15 EP claimed
WO-2001079155-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 1,4-QUINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-10-25 WO claimed